Changes in the Evaluation and Management of Adrenocortical Carcinoma Barbra S. Miller Endocrine Tumors 17 September 2018 Pages: 3413 - 3415
Omitting Completion Dissection in Melanoma? Help is Available for Surgeons Coping Without Routine Dissection, But More Work is Needed Jamie Green RandMark B. Faries Melanoma 12 September 2018 Pages: 3416 - 3418
Dynamic Behavior of Ca 19-9 and Pancreatic Cancer Recurrence: Enough Data to Drive Salvage Therapy? Giuseppe Malleo Pancreatic Tumors 20 August 2018 Pages: 3419 - 3420
Declining Use of Orthotopic Reconstruction for Bladder Cancer Richard HautmannChristian Bolenz Urologic Oncology 18 July 2018 Pages: 3421 - 3422
Patient Selection for Active Surveillance in the Multi-parametric Magnetic Resonance Imaging Era: A Step Forward in a Rapidly Evolving Field Matteo FerroVincenzo MironeMassimiliano Creta Urologic Oncology 10 September 2018 Pages: 3423 - 3424
Beyond TNM: Searching for New Patient-Centric Prognostic Indicators in NSCLC Areo G. SaffarzadehJustin D. Blasberg Thoracic Oncology 28 August 2018 Pages: 3425 - 3426
Race and Health Disparities in Patient Refusal of Surgery for Early-Stage Pancreatic Cancer: An NCDB Cohort Study Samer TohmeChristof KaltenmeierAllan Tsung Health Services Research and Global Oncology 24 July 2018 Pages: 3427 - 3435
An Examination of Applicants and Factors Associated with Matriculation to Complex General Surgical Oncology Fellowship Training Programs Michael M. WachSamantha M. RuffJonathan M. Hernandez Health Services Research and Global Oncology 27 July 2018 Pages: 3436 - 3442
ASO Author Reflections: Perspectives on the Application Process to Complex General Surgical Oncology Fellowship Training Jonathan M. Hernandez ASO Author Reflections 23 August 2018 Pages: 3443 - 3444
Evolution of a Novel Robotic Training Curriculum in a Complex General Surgical Oncology Fellowship L. Mark KnabMazen S. ZenatiMelissa E. Hogg Health Services Research and Global Oncology 02 August 2018 Pages: 3445 - 3452
Adjuvant and Neoadjuvant Therapy, Treatment for Advanced Disease, and Genetic Considerations for Adrenocortical Carcinoma: An Update from the SSO Endocrine and Head and Neck Disease Site Working Group Paxton V. DicksonLawrence KimCarmen C. Solórzano Endocrine Tumors 14 September 2018 Pages: 3453 - 3459
Evaluation, Staging, and Surgical Management for Adrenocortical Carcinoma: An Update from the SSO Endocrine and Head and Neck Disease Site Working Group Paxton V. DicksonLawrence KimCarmen C. Solórzano Endocrine Tumors 18 September 2018 Pages: 3460 - 3468
Prediction of Residual Nodal Disease at Completion Dissection Following Positive Sentinel Lymph Node Biopsy for Melanoma Andrew J. SinnamonYun SongGiorgos C. Karakousis Melanomas 24 July 2018 Pages: 3469 - 3475
Treatment of Clinically Positive Cervical Lymph Nodes by Limited Local Node Excision and Adjuvant Radiotherapy in Melanoma Patients with Major Comorbidities Hidde M. KroonWendy D. van der BolJohn F. Thompson Melanoma 16 August 2018 Pages: 3476 - 3482
CA19-9 on Postoperative Surveillance in Pancreatic Ductal Adenocarcinoma: Predicting Recurrence and Changing Prognosis over Time Caroline J. RieserMazen ZenatiMelissa E. Hogg Pancreatic Tumors 21 May 2018 Pages: 3483 - 3491
Differences in Treatment and Outcome of Pancreatic Adenocarcinoma Stage I and II in the EURECCA Pancreas Consortium J. V. GroenB. G. Sibinga MulderJ. S. D. Mieog Pancreatic Tumors Open access 27 August 2018 Pages: 3492 - 3501
Urinary Diversion After Radical Cystectomy for Bladder Cancer: Comparing Trends in the US and Germany from 2006 to 2014 Christer GroebenRainer KochJohannes Huber Urologic Oncology 21 February 2018 Pages: 3502 - 3509
Contemporary Epstein Criteria with Biopsy-Naïve Multiparametric Magnetic Resonance Imaging to Prevent Incorrect Assignment to Active Surveillance in the PI-RADS Version 2.0 Era Yu FanLingyun ZhaiJie Jin Urologic Oncology 17 September 2018 Pages: 3510 - 3517
Predictive Value of CD44 in Muscle-Invasive Bladder Cancer and Its Relationship with IL-6 Signaling Chun-Te WuWei-Yu LinMiao-Fen Chen Urologic Oncology 20 August 2018 Pages: 3518 - 3526
Multidisciplinary Management of the Axilla in Patients with cT1-T2 N0 Breast Cancer Undergoing Primary Mastectomy: Results from a Prospective Single-Institution Series Samantha GrossmithAnvy NguyenTari A. King Breast Oncology 04 June 2018 Pages: 3527 - 3534
Impact of Neoadjuvant Chemotherapy on Breast Cancer Subtype: Does Subtype Change and, if so, How? Lucy M. De La CruzMichael O. HarhayStacy Ugras Breast Oncology 06 July 2018 Pages: 3535 - 3540
Margins in Breast-Conserving Surgery After Neoadjuvant Therapy Jungeun ChoiAlison LawsTari King Breast Oncology 20 August 2018 Pages: 3541 - 3547
Implementation of a Venous Thromboembolism Prophylaxis Protocol Using the Caprini Risk Assessment Model in Patients Undergoing Mastectomy Alison LawsKathryn AndersonTari A. King Breast Oncology 20 August 2018 Pages: 3548 - 3555
Utility of Expedited Hereditary Cancer Testing in the Surgical Management of Patients with a New Breast Cancer Diagnosis Kristin A. TheobaldLisa R. SussweinBenjamin D. Solomon Breast Oncology 30 August 2018 Pages: 3556 - 3562
Patient-Reported Outcome Measures May Add Value in Breast Cancer Surgery M. LagendijkL. S. E. van EgdomL. B. Koppert Breast Oncology Open access 03 September 2018 Pages: 3563 - 3571
Robotic Versus Laparoscopic Total Mesorectal Excision for Sphincter-Saving Surgery: Results of a Single-Center Series of 400 Consecutive Patients and Perspectives Philippe RouanetMartin Marie BertrandPierre-Emmanuel Colombo Colorectal Cancer 31 August 2018 Pages: 3572 - 3579
Robotic Versus Laparoscopic Right Colectomy with Complete Mesocolic Excision for the Treatment of Colon Cancer: Perioperative Outcomes and 5-Year Survival in a Consecutive Series of 202 Patients Giuseppe SpinoglioPaolo P. BianchiEmilio Bertani Colorectal Cancer 14 September 2018 Pages: 3580 - 3586
Controversies in Surgical Oncology: Does the Minimally Invasive Approach for Rectal Cancer Provide Equivalent Oncologic Outcomes Compared with the Open Approach? Robert K. ClearyArden M. MorrisAmy L. Halverson Colorectal Cancer 05 September 2018 Pages: 3587 - 3595
Optimal Cutoff Values of Skeletal Muscle Index to Define Sarcopenia for Prediction of Survival in Patients with Advanced Gastric Cancer Tatsuto NishigoriShigeru TsunodaYoshiharu Sakai Gastrointestinal Oncology 30 August 2018 Pages: 3596 - 3603
Surgical Outcomes of Reduced-Port Laparoscopic Gastrectomy Versus Conventional Laparoscopic Gastrectomy for Gastric Cancer: A Propensity-Matched Retrospective Cohort Study Chikara KunisakiHiroshi MiyamotoItaru Endo Gastrointestinal Oncology 03 September 2018 Pages: 3604 - 3612
Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors David StrosbergEric B. SchneiderLawrence A. Shirley Gastrointestinal Oncology 04 September 2018 Pages: 3613 - 3620
Factors Associated With Host Immune Response and Number of Lymph Nodes: A Large Retrospective Cohort Study Sun-Ju ByeonYou Jeong HeoTae Sung Sohn Gastrointestinal Oncology 04 September 2018 Pages: 3621 - 3628
Comparison of Outcomes for Elderly Gastric Cancer Patients at Least 80 Years of Age Following Gastrectomy in the United States and China Jian-xian LinBrendan C. YiSam S. Yoon Gastrointestinal Oncology 14 September 2018 Pages: 3629 - 3638
Recurrence Risk Based on Pathologic Stage After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Implications for Risk-Based Postoperative Surveillance Strategies Sha ZhouShiliang LiuMian Xi Thoracic Oncology 07 September 2018 Pages: 3639 - 3646
Prognostic Significance of Albumin–Globulin Score in Patients with Operable Non-Small-Cell Lung Cancer Xiang LiSida QinHong Ren Thoracic Oncology Open access 18 September 2018 Pages: 3647 - 3659
Abilities of Pre- and Postoperative High-Sensitivity C-Reactive Protein Levels to Predict 90-Day Mortality After Surgery for Abdominal and Thoracic Cancers Tak Kyu OhYoungRok ChoiJung-Hee Ryu Thoracic Oncology 03 September 2018 Pages: 3660 - 3666
Abilities of Pre- and Postoperative High-Sensitivity C-Reactive Protein Levels to Predict 90-Day Mortality After Surgery for Abdominal and Thoracic Cancers Tak Kyu OhJung-Hee Ryu ASO Author Reflections 30 August 2018 Pages: 3667 - 3667
Nodule Size After Chemotherapy and Primary-Tumor Teratoma Components Predict Malignancy of Residual Pulmonary Nodules in Metastatic Nonseminomatous Germ Cell Tumor Yuta ToyoshimaTomohiko HaraHiroyuki Fujimoto Thoracic Oncology 06 September 2018 Pages: 3668 - 3675
Proposal for a Risk-Based Categorization of Uterine Carcinosarcoma Koji MatsuoYutaka TakazawaLynda D. Roman Gynecologic Oncology 13 August 2018 Pages: 3676 - 3684
Minority Race Predicts Treatment by Non-gynecologic Oncologists in Women with Gynecologic Cancer Amin A. RamzanKian BehbakhtSaketh R. Guntupalli Gynecologic Oncology 13 August 2018 Pages: 3685 - 3691
Frozen Section for Detection of Lymph Nodes After Cervical Injection with Indocyanine Green (ICG) for Sentinel Lymph Node Technique in Endometrial Cancer Staging Jvan CasarinFrancesco MultinuGretchen Glaser Gynecologic Oncology 16 August 2018 Pages: 3692 - 3698
Frozen Section to Detect Empty Nodes and Improve the Accuracy of the Sentinel Lymph Node Biopsy in Endometrial Cancer Jvan CasarinGretchen Glaser ASO Author Reflections 17 September 2018 Pages: 3699 - 3700
BRCA Mutation Status to Personalize Management of Recurrent Ovarian Cancer: A Multicenter Study Claudia MarchettiRossella De LeoAnna Fagotti Gynecologic Oncology 20 August 2018 Pages: 3701 - 3708
ASO Author Reflections: BRCA Mutation Status for Personalizing Management of Recurrent Ovarian Cancer—A Multicenter Study Anna Fagotti ASO Author Reflections 03 September 2018 Pages: 3709 - 3710
Identification of the Thoracic Duct Using Indocyanine Green During Cervical Lymphadenectomy Jeffery ChakedisLawrence A. ShirleyJohn E. Phay Head and Neck Oncology 03 August 2018 Pages: 3711 - 3717
ASO Author Reflections: Identification of the Thoracic Duct using Indocyanine Green During Cervical Lymphadenectomy Jeffery ChakedisJohn E. Phay ASO Author Reflections 31 August 2018 Pages: 3718 - 3718
Patterns of Distribution of Hepatic Nodules (Single, Satellites or Multifocal) in Intrahepatic Cholangiocarcinoma: Prognostic Impact After Surgery Simone ConciAndrea RuzzenenteAlfredo Guglielmi Hepatobiliary Tumors 07 August 2018 Pages: 3719 - 3727
Hypoxia-Induced PLOD2 is a Key Regulator in Epithelial-Mesenchymal Transition and Chemoresistance in Biliary Tract Cancer Yuichiro OkumuraTakehiro NodaMasaki Mori Translational Research and Biomarkers 13 August 2018 Pages: 3728 - 3737
ASO Author Reflections: Hypoxia-Induced PLOD2 Is a Key Regulator in Epithelial–Mesenchymal Transition and Chemoresistance in Biliary Tract Cancer Yuichiro OkumuraHidetoshi Eguchi ASO Author Reflections 30 August 2018 Pages: 3738 - 3739
Doppler Ultrasound-Visible SignalMark Microspheres are Better Identified than HydroMARK® Clips in a Simulated Intraoperative Setting in Breast and Lung Tissue Rachel K. VossErin P. WardSarah L. Blair Translational Research and Biomarkers 03 September 2018 Pages: 3740 - 3746